ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Kansas » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Kansas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RICHARD GOMENDOZA M.D.

Endocrinology, Diabetes Metabolism

4,731

$703K

480
342 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

63%
prescriptions for brand name drugs

Avg: 52%

$149
Average prescription price

Avg: $159

RICHARD GUTHRIE M.D.

Endocrinology, Diabetes Metabolism

4,643

$776K

456
325 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

57%
prescriptions for brand name drugs

Avg: 52%

$167
Average prescription price

Avg: $159

JAN HOFFMAN MD

Endocrinology, Diabetes Metabolism

3,891

$690K

578
462 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

61%
prescriptions for brand name drugs

Avg: 52%

$177
Average prescription price

Avg: $159

FRANCISCO CORREA M.D

Endocrinology, Diabetes Metabolism

3,615

$229K

237
153 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 52%

$63
Average prescription price

Avg: $159

JEFFREY FAJARDO MD

Endocrinology, Diabetes Metabolism

3,557

$597K

344
239 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 52%

$168
Average prescription price

Avg: $159

JEFFREY KALLSEN M.D.

Endocrinology, Diabetes Metabolism

3,160

$549K

357
285 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 52%

$174
Average prescription price

Avg: $159

ANDREW GREEN M.D.

Endocrinology, Diabetes Metabolism

2,960

$526K

320
272 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 52%

$178
Average prescription price

Avg: $159

MICHAEL SOKOL MD

Endocrinology, Diabetes Metabolism

2,946

$532K

270
214 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

55%
prescriptions for brand name drugs

Avg: 52%

$181
Average prescription price

Avg: $159

LISA HAYS M.D.

Endocrinology, Diabetes Metabolism

2,740

$435K

342
268 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

55%
prescriptions for brand name drugs

Avg: 52%

$159
Average prescription price

Avg: $159

ALAN WYNNE M.D.

Endocrinology, Diabetes Metabolism

2,634

$574K

431
282 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 52%

$218
Average prescription price

Avg: $159

MARIE GRIFFIN M.D.

Endocrinology, Diabetes Metabolism

2,632

$297K

239
189 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 52%

$113
Average prescription price

Avg: $159

MOHAMMED MOUNLA M.D.

Endocrinology, Diabetes Metabolism

2,396

$445K

322
211 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 52%

$186
Average prescription price

Avg: $159

SAJEEV MENON MD

Endocrinology, Diabetes Metabolism

2,261

$311K

233
173 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 52%

$138
Average prescription price

Avg: $159

CHARYSE SINDLER M.D.

Endocrinology, Diabetes Metabolism

2,114

$389K

183
124 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 52%

$184
Average prescription price

Avg: $159

DANY ZAYOUR MD

Endocrinology, Diabetes Metabolism

1,783

$272K

214
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

62%
prescriptions for brand name drugs

Avg: 52%

$153
Average prescription price

Avg: $159

SAHAR HACHEM MD

Endocrinology, Diabetes Metabolism

1,492

$206K

195
125 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 52%

$138
Average prescription price

Avg: $159

JUSTIN MOORE MD

Endocrinology, Diabetes Metabolism

1,410

$192K

166
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 52%

$136
Average prescription price

Avg: $159

MINI ABRAHAM M.D.

Endocrinology, Diabetes Metabolism

1,382

$220K

139
92 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

59%
prescriptions for brand name drugs

Avg: 52%

$159
Average prescription price

Avg: $159

LELAND GRAVES M.D.

Endocrinology, Diabetes Metabolism

1,346

$251K

194
114 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 52%

$186
Average prescription price

Avg: $159

MARIA GOMES M.D.

Endocrinology, Diabetes Metabolism

1,340

$238K

189
135 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

61%
prescriptions for brand name drugs

Avg: 52%

$178
Average prescription price

Avg: $159

SUSAN BRIAN MD

Endocrinology, Diabetes Metabolism

1,322

$266K

166
107 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 52%

$201
Average prescription price

Avg: $159

EFREM GEBREMEDHIN M.D

Endocrinology, Diabetes Metabolism

1,045

$188K

95
56 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 52%

$180
Average prescription price

Avg: $159

JOSEPH MEEK M.D.

Endocrinology, Diabetes Metabolism

613

$30.5K

80
59 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

65%
prescriptions for brand name drugs

Avg: 52%

$50
Average prescription price

Avg: $159

RICHARD FAIRCHILD MD

Endocrinology, Diabetes Metabolism

346

$52K

63
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

55%
prescriptions for brand name drugs

Avg: 52%

$150
Average prescription price

Avg: $159

RAMI MORTADA MD

Endocrinology, Diabetes Metabolism

200

$18.9K

36
17 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 52%

$94
Average prescription price

Avg: $159

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank